Cryptococcal Meningitis in Senegal: Epidemiology, Laboratory Findings, Therapeutic and Outcome of Cases Diagnosed from 2004 to 2011
Cryptococcal meningitis is one of the most important opportunistic infection and a major contributor to early mortality. In sub-Saharan Africa, particularly in Senegal, prevalence of cryptococcal meningitis remains high. This study aimed to describe the epidemiology, laboratory profile, therapeutic and outcome of cases diagnosed in Dakar.
We analyzed the cryptococcosis cases diagnosed at the department of parasitology–mycology in Fann Teaching Hospital in Dakar from 2004 to 2011. The diagnosis was confirmed by culture on Sabouraud’s dextrose agar and/or by India ink preparation and/or by cryptococcal antigen detection. The diagnosis methods were assessed by using culture as reference.
A total of 106 cases of cryptococcal meningitis were diagnosed. The prevalence of cryptococcal meningitis was 7.8 %. The mean age of the patients was 40.17 ± 9.89 years. There were slightly more male (53.8 %) than female (46.2 %) patients; 89.6 % were found to be infected with HIV, and the median CD4+ count was 27/mm3. Approximately 79.5 % of the patients had <100 CD4+ lymphocytes/mm3. India ink staining presented sensitivity at 94.11 % and specificity at 100 %. Sensitivity and specificity of cryptococcal antigen detection in cerebrospinal fluid were, respectively, 96.96 and 15.78 %. The most frequently used antifungal drug was fluconazole (86.7 %), and the mortality rate was 62.2 % (66 deaths).
Early diagnosis is essential to control cryptococcosis, and countries should prioritize widespread and reliable access to rapid diagnostic cryptococcus antigen assays. But it is important to make available conventional methods (India ink and culture) in the maximum of laboratory in regional health facilities.
KeywordsCryptococcal meningitis Epidemiology Laboratory profile Therapeutic Outcome
Conflict of interest
- 2.WHO: rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Geneva 2011. (http://www.who.int/about/licensing/ copyright_form/en/index.html).
- 13.Soumaré M, Seydi M, Ndour CT, Dieng Y, Diouf AM, Diop BM. Aspects actuels de la cryptococcose neuro-méningée à Dakar. Med Trop. 2005;65:559–60.Google Scholar
- 22.Ki-zerbo GA, Sawadogo A, Andonaba JB, Yemeogo A, Ouedraogo I, Tamini M, et al. La Cryptococcose neuroméningée au cours du SIDA au centre hospitalier de Bobodioulasso: Etude préliminaire à l’hôpital de Bobodioulasso. Med d’Afr Noire. 1996;43(1):63–5.Google Scholar
- 27.Dromer F, Lortholary O. Cryptococcose. Encyclopédie Médico-Chirurgicale. 2004;8:613.Google Scholar
- 29.Ondounda M, Mounguengui D, Mandji LJ, Magne C, Nziengui MM, Kombila U, Nzenze JR. Neuromeningeal cryptococcosis and AIDS: an 11-case series from Libreville, Gabon. Med Trop. 2010;70:406.Google Scholar